Kanada - angielski - Health Canada

gw pharma limited - delta-9-tetrahydrocannabinol (cannabis sativa extract); cannabidiol (cannabis sativa extract) - spray - 2.7mg; 2.5mg - delta-9-tetrahydrocannabinol (cannabis sativa extract) 2.7mg; cannabidiol (cannabis sativa extract) 2.5mg - miscellaneous therapeutic agents

Australia - angielski - Department of Health (Therapeutic Goods Administration)

medlab clinical ltd - cannabidiol,tetrahydrocannabinol -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

althea company pty ltd - cannabidiol, quantity: 12.5 mg/ml; tetrahydrocannabinol, quantity: 10 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides

Australia - angielski - Department of Health (Therapeutic Goods Administration)

onelife labs pty ltd - tetrahydrocannabinol, quantity: 12.5 mg/ml; cannabidiol, quantity: 12.5 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides

Australia - angielski - Department of Health (Therapeutic Goods Administration)

onelife labs pty ltd - tetrahydrocannabinol, quantity: 12.5 mg/ml; cannabidiol, quantity: 12.5 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides

Australia - angielski - Department of Health (Therapeutic Goods Administration)

medlab clinical ltd - cannabidiol, quantity: 9.62 mg/ml; tetrahydrocannabinol, quantity: 9.62 mg/ml - spray, solution - excipient ingredients: citric acid; glycerol; peppermint oil; peg-40 castor oil; medium chain triglycerides; potassium sorbate; sucralose

Australia - angielski - Department of Health (Therapeutic Goods Administration)

little green pharma ltd - tetrahydrocannabinol, quantity: 20 mg/ml; cannabidiol, quantity: 5 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides - there is growing evidence that medicinal cannabis can benefit patients in a variety of clinical settings. based on this, the lgp classic oil range including 10:10 lgp classic, and 20:5 lgp classic as medicinal cannabis products, may have a role in medical conditions including:? intractable chronic pain insufficiently responsive to other analgesics;? pain associated with spasticity in multiple sclerosis;? pain associated with cancer in palliative care;? cancer treatment-induced nausea and vomiting;? appetite loss;? insomnia;? post-traumatic stress disorder ? cachexia

Australia - angielski - Department of Health (Therapeutic Goods Administration)

little green pharma ltd - cannabidiol, quantity: 10 mg/ml; tetrahydrocannabinol, quantity: 10 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides - there is growing evidence that medicinal cannabis can benefit patients in a variety of clinical settings. based on this, the lgp classic oil range as medicinal cannabis products may have a role in medical conditions including: ? intractable chronic pain insufficiently responsive to other analgesics ? pain associated with spasticity in multiple sclerosis ? pain associated with cancer in palliative care ? cancer treatment-induced nausea and vomiting ? appetite loss ? insomnia ? post-traumatic stress disorder ? cachexia

Australia - angielski - Department of Health (Therapeutic Goods Administration)

little green pharma ltd - tetrahydrocannabinol, quantity: 10 mg/ml; cannabidiol, quantity: 10 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides - there is growing evidence that medicinal cannabis can benefit patients in a variety of clinical settings. based on this, lgp classic oil range as medicinal cannabis products may have a role in medical conditions including: ? intractable chronic pain insufficiently responsive to other analgesics ? pain associated with spasticity in multiple sclerosis;? pain associated with cancer in palliative care;? cancer treatment-induced nausea and vomiting;? appetite loss;? insomnia? post-traumatic stress disorder;? cachexia

Australia - angielski - Department of Health (Therapeutic Goods Administration)

little green pharma ltd - cannabidiol, quantity: 20 mg/ml; tetrahydrocannabinol, quantity: 1 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides - there is growing evidence that medicinal cannabis can benefit patients in a variety of clinical settings. based on this, the lgp classic oil range including 10:10 lgp classic, and 20:5 lgp classic as medicinal cannabis products, may have a role in medical conditions including:behavioural issues associated with autism, ? intractable epileptic seizures in adults and children, ? intractable chronic pain insufficiently responsive to other analgesics ? pain associated with spasticity in multiple sclerosis ? pain associated with cancer in palliative care ? cancer treatment-induced nausea and vomiting ? appetite loss ? insomnia ? post-traumatic stress disorder ? cachexia